RGPD4
gene geneOn this page
Also known as RGP4DKFZp686P0288
Summary
RGPD4 (RANBP2 like and GRIP domain containing 4, HGNC:32417) is a protein-coding gene on chromosome 2q12.3, encoding RanBP2-like and GRIP domain-containing protein 4 (Q7Z3J3). It is a selective cancer dependency (DepMap: 16.4% of cell lines).
Predicted to contribute to GTPase activator activity. Predicted to be involved in NLS-bearing protein import into nucleus. Predicted to be part of nuclear pore. Predicted to be active in cytoplasm.
Source: NCBI Gene 285190 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 373 total
- Cancer dependency (DepMap): dependent in 16.4% of screened cell lines
- MANE Select transcript:
NM_182588
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:32417 |
| Approved symbol | RGPD4 |
| Name | RANBP2 like and GRIP domain containing 4 |
| Location | 2q12.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | RGP4, DKFZp686P0288 |
| Ensembl gene | ENSG00000196862 |
| Ensembl biotype | protein_coding |
| OMIM | 612707 |
| Entrez | 285190 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000408999
RefSeq mRNA: 1 — MANE Select: NM_182588
NM_182588
CCDS: CCDS46381
Canonical transcript exons
ENST00000408999 — 23 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001872929 | 107826892 | 107827085 |
| ENSE00001910458 | 107890721 | 107892544 |
| ENSE00002445986 | 107861194 | 107861331 |
| ENSE00002452314 | 107862949 | 107863032 |
| ENSE00002455397 | 107869883 | 107869977 |
| ENSE00002457670 | 107859722 | 107859845 |
| ENSE00002464767 | 107843009 | 107843239 |
| ENSE00002471423 | 107838812 | 107838964 |
| ENSE00002478426 | 107843585 | 107843730 |
| ENSE00002483308 | 107861594 | 107861740 |
| ENSE00002483655 | 107882672 | 107882873 |
| ENSE00002483815 | 107854556 | 107854643 |
| ENSE00002486568 | 107866190 | 107866325 |
| ENSE00002495853 | 107836602 | 107836669 |
| ENSE00002500115 | 107862682 | 107862861 |
| ENSE00002505121 | 107838257 | 107838368 |
| ENSE00002514284 | 107879968 | 107880107 |
| ENSE00002520911 | 107859114 | 107859295 |
| ENSE00002524501 | 107870705 | 107872928 |
| ENSE00002525608 | 107859379 | 107859554 |
| ENSE00002526803 | 107860766 | 107860927 |
| ENSE00002527577 | 107856760 | 107856969 |
| ENSE00002530598 | 107848341 | 107848536 |
Expression profiles
Bgee: expression breadth ubiquitous, 120 present calls, max score 76.70.
Top tissues by expression
131 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 76.70 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 75.24 | gold quality |
| testis | UBERON:0000473 | 62.13 | gold quality |
| left testis | UBERON:0004533 | 61.38 | gold quality |
| right testis | UBERON:0004534 | 61.06 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 59.85 | gold quality |
| ventricular zone | UBERON:0003053 | 57.98 | gold quality |
| primary visual cortex | UBERON:0002436 | 56.96 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 56.24 | gold quality |
| islet of Langerhans | UBERON:0000006 | 54.64 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 54.17 | gold quality |
| ganglionic eminence | UBERON:0004023 | 53.04 | silver quality |
| granulocyte | CL:0000094 | 52.29 | gold quality |
| endometrium | UBERON:0001295 | 51.05 | gold quality |
| urinary bladder | UBERON:0001255 | 50.86 | gold quality |
| pancreas | UBERON:0001264 | 50.55 | gold quality |
| right lobe of liver | UBERON:0001114 | 50.43 | gold quality |
| tibial artery | UBERON:0007610 | 50.24 | gold quality |
| popliteal artery | UBERON:0002250 | 50.23 | gold quality |
| colonic epithelium | UBERON:0000397 | 50.09 | gold quality |
| putamen | UBERON:0001874 | 50.08 | gold quality |
| muscle of leg | UBERON:0001383 | 49.95 | gold quality |
| gastrocnemius | UBERON:0001388 | 49.90 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 49.78 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 49.27 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 49.23 | gold quality |
| liver | UBERON:0002107 | 49.18 | silver quality |
| lower esophagus mucosa | UBERON:0035834 | 49.11 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 49.09 | gold quality |
| body of pancreas | UBERON:0001150 | 48.98 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
113 targeting RGPD4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-513A-5P | 100.00 | 69.77 | 2465 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-12118 | 100.00 | 65.88 | 1270 |
| HSA-MIR-450A-1-3P | 100.00 | 69.33 | 1837 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-4425 | 100.00 | 67.59 | 1049 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-1184 | 99.99 | 68.19 | 1458 |
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-MIR-103A-3P | 99.98 | 69.14 | 1595 |
| HSA-MIR-107 | 99.98 | 69.14 | 1595 |
| HSA-MIR-6891-5P | 99.98 | 66.53 | 1372 |
| HSA-MIR-3173-3P | 99.98 | 66.49 | 1217 |
| HSA-LET-7F-2-3P | 99.98 | 70.98 | 2588 |
| HSA-MIR-1185-1-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-1185-2-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-485-3P | 99.98 | 70.68 | 1585 |
| HSA-MIR-539-3P | 99.98 | 70.74 | 1616 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-4267 | 99.96 | 66.53 | 2368 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 16.4% of screened cell lines.
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ranbp3a | ENSDARG00000008727 |
| drosophila_melanogaster | RanBP3 | FBGN0039110 |
Paralogs (10): RGPD5 (ENSG00000015568), RANBP3 (ENSG00000031823), RANBP1 (ENSG00000099901), RGPD3 (ENSG00000153165), RANBP2 (ENSG00000153201), RANBP3L (ENSG00000164188), RGPD8 (ENSG00000169629), RGPD6 (ENSG00000183054), RGPD2 (ENSG00000185304), RGPD1 (ENSG00000187627)
Protein
Protein identifiers
RanBP2-like and GRIP domain-containing protein 4 — Q7Z3J3 (reviewed: Q7Z3J3)
All UniProt accessions (1): Q7Z3J3
UniProt curated annotations — full annotation on UniProt →
Miscellaneous. One of the 8 copies of RANBP2 clustered close to the chromosome 2 centromere.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q7Z3J3-1 | 1 | yes |
| Q7Z3J3-2 | 2 |
RefSeq proteins (1): NP_872394* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000156 | Ran_bind_dom | Domain |
| IPR000237 | GRIP_dom | Domain |
| IPR011990 | TPR-like_helical_dom_sf | Homologous_superfamily |
| IPR011993 | PH-like_dom_sf | Homologous_superfamily |
| IPR019734 | TPR_rpt | Repeat |
| IPR032023 | GCC2_Rab_bind | Domain |
| IPR045255 | RanBP1-like | Family |
Pfam: PF00638, PF01465, PF13181, PF16704
UniProt features (19 total): compositionally biased region 6, region of interest 4, domain 3, repeat 2, splice variant 2, chain 1, modified residue 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q7Z3J3-F1 | 67.37 | 0.27 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 21
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 55 (showing top):
GOBP_INTRACELLULAR_PROTEIN_TRANSPORT, chr2q12, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE, GOBP_NUCLEAR_TRANSPORT, MARZEC_IL2_SIGNALING_DN, GOBP_PROTEIN_LOCALIZATION_TO_ORGANELLE, GOBP_NLS_BEARING_PROTEIN_IMPORT_INTO_NUCLEUS, GOBP_NUCLEAR_EXPORT, GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS, GOBP_PROTEIN_LOCALIZATION_TO_NUCLEUS, GOCC_NUCLEAR_ENVELOPE, GOCC_NUCLEAR_PORE, GOMF_ACYLTRANSFERASE_ACTIVITY, GOMF_SUMO_TRANSFERASE_ACTIVITY, GOMF_AMINOACYLTRANSFERASE_ACTIVITY
GO Biological Process (2): NLS-bearing protein import into nucleus (GO:0006607), intracellular transport (GO:0046907)
GO Molecular Function (2): GTPase activator activity (GO:0005096), protein binding (GO:0005515)
GO Cellular Component (2): nuclear pore (GO:0005643), cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular anatomical structure | 2 |
| protein import into nucleus | 1 |
| transport | 1 |
| cellular localization | 1 |
| establishment of localization in cell | 1 |
| GTPase activity | 1 |
| enzyme activator activity | 1 |
| GTPase regulator activity | 1 |
| binding | 1 |
| nuclear envelope | 1 |
| nuclear protein-containing complex | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1636 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RGPD4 | GRIP1 | Q9Y3R0 | 706 |
| RGPD4 | USP17L13 | C9JLJ4 | 570 |
| RGPD4 | SUMO1 | P55856 | 471 |
| RGPD4 | C16orf90 | A8MZG2 | 440 |
| RGPD4 | WFDC11 | Q8NEX6 | 436 |
| RGPD4 | IQCF3 | P0C7M6 | 413 |
| RGPD4 | SPANXN5 | Q5MJ07 | 405 |
| RGPD4 | AADACL2 | Q6P093 | 395 |
| RGPD4 | TXNDC8 | Q6A555 | 369 |
| RGPD4 | DEFB112 | Q30KQ8 | 368 |
| RGPD4 | GCC2 | Q8IWJ2 | 366 |
| RGPD4 | POTEH | Q6S545 | 355 |
| RGPD4 | SH3TC1 | Q8TE82 | 349 |
| RGPD4 | CIB4 | A0PJX0 | 338 |
| RGPD4 | SIRAL2 | Q9NWS6 | 326 |
IntAct
9 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CFTR | ESYT2 | psi-mi:“MI:0914”(association) | 0.710 |
| RAN | RGPD8 | psi-mi:“MI:0914”(association) | 0.640 |
| PLK1 | ERCC6L | psi-mi:“MI:0914”(association) | 0.350 |
| UVRAG | DFFA | psi-mi:“MI:0914”(association) | 0.350 |
| KPNA4 | POM121C | psi-mi:“MI:0914”(association) | 0.350 |
| NUMA1 | SHANK3 | psi-mi:“MI:0914”(association) | 0.350 |
| RAN | NUP214 | psi-mi:“MI:0914”(association) | 0.350 |
| CIB2 | APAF1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (24): RGPD4 (Affinity Capture-MS), RGPD4 (Affinity Capture-MS), RGPD4 (Affinity Capture-MS), RGPD4 (Affinity Capture-MS), RGPD4 (Affinity Capture-MS), RGPD4 (Affinity Capture-MS), RGPD4 (Affinity Capture-MS), RGPD4 (Affinity Capture-MS), RGPD4 (Affinity Capture-MS), RGPD4 (Affinity Capture-MS), RGPD4 (Proximity Label-MS), RGPD4 (Affinity Capture-MS), RGPD5 (Cross-Linking-MS (XL-MS)), RGPD4 (Cross-Linking-MS (XL-MS)), RGPD4 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A0A0B4K7J2, A1ZAK1, A6NKT7, F4J8D3, G5ED39, H2QII6, O01510, O14715, O48767, P0DJD0, P0DJD1, P12798, P33144, P40358, P42286, P49792, Q00416, Q0IEK6, Q18508, Q18892, Q20937, Q291E4, Q2U639, Q4WVM7, Q5B8K7, Q61CW2, Q61WP7, Q6C9G0, Q6CXL5, Q6FUS3, Q6FVG5, Q70PP2, Q751J3, Q754V0, Q759B7, Q759Y1, Q75B70, Q75CM2, Q7TSH2, Q7Z3J3
Diamond homologs: A0A0B4K7J2, A6NKT7, E9Q3G8, H2QII6, O14715, P0DJD0, P0DJD1, P34022, P40517, P41920, P43487, P92985, Q09717, Q3T0M7, Q54KD9, Q7Z3J3, Q8RWG8, Q99666, Q9C829, Q9LMK7, Q9USL4, D3ZZL9, P32499, P34562, P48820, P49792, Q8CHG3, Q8IWJ2, Q9ERU9, G0S8I1, Q09146, Q86VV4, A0A075B759, A0A075B767, A0A0B4J2A2, A0A0R0H9T5, A4FV72, D4AY02, F5H284, O00060
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
373 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 328 |
| Likely benign | 38 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3082 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:107836596:TTTTA:T | acceptor_loss | 1.0000 |
| 2:107836597:TTTAG:T | acceptor_loss | 1.0000 |
| 2:107836599:TA:T | acceptor_loss | 1.0000 |
| 2:107836600:A:AG | acceptor_gain | 1.0000 |
| 2:107836600:A:T | acceptor_loss | 1.0000 |
| 2:107836601:G:GT | acceptor_gain | 1.0000 |
| 2:107836601:GA:G | acceptor_gain | 1.0000 |
| 2:107836601:GAA:G | acceptor_gain | 1.0000 |
| 2:107836601:GAAGT:G | acceptor_gain | 1.0000 |
| 2:107836665:AAAAA:A | donor_gain | 1.0000 |
| 2:107836666:AAAA:A | donor_gain | 1.0000 |
| 2:107836666:AAAAG:A | donor_loss | 1.0000 |
| 2:107836667:AAA:A | donor_gain | 1.0000 |
| 2:107836667:AAAGT:A | donor_loss | 1.0000 |
| 2:107836668:AA:A | donor_gain | 1.0000 |
| 2:107836668:AAGT:A | donor_loss | 1.0000 |
| 2:107836669:AG:A | donor_loss | 1.0000 |
| 2:107836670:G:GG | donor_gain | 1.0000 |
| 2:107836670:G:T | donor_loss | 1.0000 |
| 2:107836671:TAA:T | donor_loss | 1.0000 |
| 2:107838248:A:AG | acceptor_gain | 1.0000 |
| 2:107838249:A:G | acceptor_gain | 1.0000 |
| 2:107838255:A:AG | acceptor_gain | 1.0000 |
| 2:107838256:G:GG | acceptor_gain | 1.0000 |
| 2:107838256:GATAC:G | acceptor_gain | 1.0000 |
| 2:107838365:CAGGG:C | donor_loss | 1.0000 |
| 2:107838366:AGGGT:A | donor_loss | 1.0000 |
| 2:107838367:GG:G | donor_gain | 1.0000 |
| 2:107838368:GG:G | donor_gain | 1.0000 |
| 2:107838369:G:GA | donor_loss | 1.0000 |
AlphaMissense
11578 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:107859822:T:A | W579R | 0.995 |
| 2:107859822:T:C | W579R | 0.995 |
| 2:107859155:T:A | W440R | 0.994 |
| 2:107859155:T:C | W440R | 0.994 |
| 2:107859517:T:A | W533R | 0.994 |
| 2:107859517:T:C | W533R | 0.994 |
| 2:107859754:T:A | V556D | 0.994 |
| 2:107860814:A:C | S603R | 0.994 |
| 2:107860816:T:A | S603R | 0.994 |
| 2:107860816:T:G | S603R | 0.994 |
| 2:107859514:T:A | W532R | 0.993 |
| 2:107859514:T:C | W532R | 0.993 |
| 2:107861324:T:C | L684P | 0.992 |
| 2:107854634:A:C | S353R | 0.991 |
| 2:107854636:C:A | S353R | 0.991 |
| 2:107854636:C:G | S353R | 0.991 |
| 2:107859287:G:C | D484H | 0.991 |
| 2:107859291:T:C | L485P | 0.991 |
| 2:107859386:T:C | L489P | 0.991 |
| 2:107859391:G:A | G491R | 0.991 |
| 2:107859391:G:C | G491R | 0.991 |
| 2:107859835:T:C | L583P | 0.991 |
| 2:107861691:T:C | L719P | 0.991 |
| 2:107859210:T:C | L458P | 0.990 |
| 2:107859276:T:A | I480K | 0.990 |
| 2:107860813:A:C | R602S | 0.990 |
| 2:107860813:A:T | R602S | 0.990 |
| 2:107859288:A:C | D484A | 0.989 |
| 2:107843210:T:A | W203R | 0.988 |
| 2:107843210:T:C | W203R | 0.988 |
dbSNP variants (sampled 300 via entrez): RS1000017831 (2:107836132 G>A), RS1000018256 (2:107855354 C>T), RS1000149172 (2:107845544 G>A,C,T), RS1000194393 (2:107887923 T>A,C), RS1000203318 (2:107845123 C>T), RS1000453093 (2:107855537 C>T), RS1000476870 (2:107831670 G>A,T), RS1000600839 (2:107825016 T>C), RS1000607198 (2:107884582 T>A,G), RS1000733399 (2:107878506 A>G), RS1000804820 (2:107879656 G>A), RS1000849302 (2:107832049 T>C), RS1000879929 (2:107861934 G>A,T), RS1001039938 (2:107884877 G>A), RS1001053886 (2:107854049 C>G)
Disease associations
OMIM: gene MIM:612707 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Resveratrol | increases expression, affects cotreatment | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.